Genetic testing ruled out
Life insurance companies will not require policy holders to undergo genetic testing under a ruling delivered by the Australian Competition and Consumer Commission (ACCC) yesterday.
The decision has been supported by the Investment and Financial Services Association (IFSA) who have formulated a policy that sought to keep genetic testing out of the life insurance market.
To ensure competition between companies is not under threat the ACCC has said IFSA members will not encourage life insurance applicants to undergo testing by offering discounts on premiums for favourable test results.
At present life companies who are part of IFSA make up 98 per cent of Australia's life insurance industry,
IFSA chief executive officer Lynn Ralph says, "the ACCC decision provides a sensible basis for the industry to continue to provide affordable life insurance."
The proposed agreement has been authorised for a period of two years to allow time for government policy to be developed, says ACCC chairman professor Allan Fels.
The Australian Law Reform Commission (ALRC) and Medical Research Council are conducting their own joint inquiry into human genetic information privacy and discrimination issues.
IFSA members however will continue to request that existing genetic test information be disclosed in the assessing of life products.
Currently five million Australians have some sort of life product according to IFSA data with approximately $366 billion of life cover being provided.
Recommended for you
With the final tally for FY25 now confirmed, how many advisers left during the financial year and how does it compare to the previous year?
HUB24 has appointed Matt Willis from Vanguard as an executive general manager of platform growth to strengthen the platform’s relationships with industry stakeholders.
Investment manager Drummond Capital Partners has announced a raft of adviser-focused updates, including a practice growth division, relaunched manager research capabilities, and a passive model portfolio suite.
When it comes to M&A activity, the share of financial buyers such as private equity firms in Australia fell from 67 per cent to 12 per cent in the last financial year.